Patients with normal BMD at trial entry

Patients who received any prior bisphosphonate therapy in the past 12 months

Treatment with anti-androgen mono- or combination therapy

Patients who are currently receiving diethylstilbesterol (DES) or who have previously received PC-SPES

Patients who have received prior treatment with systemic corticosteroids within the past 12 months

Patients with prior exposure to anabolic steroids or growth hormone within the past 6 months

Patients with any prior treatment for osteoporosis

Maintaining Bone Strength in Men With Prostate Cancer